Treatment with miglustat reverses the lipid-trafficking defect in Niemann–Pick disease type C
Niemann–Pick disease type C (NP-C) is a hereditary neurovisceral lipid storage disorder. Although traditionally considered a primary cholesterol storage disorder, a variety of glycolipids accumulate in NP-C cells, which resemble those from glycosphingolipidosis patients. Substrate reduction therapy...
Main Authors: | Robin H Lachmann, Danielle te Vruchte, Emyr Lloyd-Evans, Gabriele Reinkensmeier, Daniel J Sillence, Luisa Fernandez-Guillen, Raymond A Dwek, Terry D Butters, Timothy M Cox, Frances M Platt |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2004-08-01
|
Series: | Neurobiology of Disease |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S0969996104001111 |
Similar Items
-
Miglustat therapy in the French cohort of paediatric patients with Niemann-Pick disease type C
by: Héron Bénédicte, et al.
Published: (2012-06-01) -
Miglustat in Niemann-Pick disease type C patients: a review
by: Mercè Pineda, et al.
Published: (2018-08-01) -
Improved neuroprotection using miglustat, curcumin and ibuprofen as a triple combination therapy in Niemann–Pick disease type C1 mice
by: Ian M. Williams, et al.
Published: (2014-07-01) -
Adult Niemann-Pick disease type C in France: clinical phenotypes and long-term miglustat treatment effect
by: Yann Nadjar, et al.
Published: (2018-10-01) -
Favorable outcomes following early onset oral miglustat in early infantile Niemann Pick Type C
by: Shiri Curelaru, et al.
Published: (2021-06-01)